KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Clinical trial NCT03919799 · TERMINATED

Trial details

NCT number: NCT03919799
Sponsor: Kadmon, a Sanofi Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

System; Sclerosis Diffuse Cutaneous Systemic Sclerosis

Start date: 2019-06-26
Primary completion: 2022-08-09
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.